| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.65 | 0.01 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |